Theiss HD, Brenner C, Engelmann MG, Zaruba MM, Huber B, Henschel V, Mansmann U, Wintersperger B, Reiser M, Steinbeck G, et al: Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI-Trial)rationale, design and first interim analysis
"MOTS-c levels in human blood decline with age and correlate with insulin sensitivity, positioning the peptide not just as a metabolic tool but as a potential biomarker of mitochondrial vitality." On the exercise side, a pivotal finding came from studies measuring endogenous MOTS-c in human subjects
Significantly, it lowers the volume of food noiseintense food cravings for sugary, fatty, and processed foods, making it easier to make healthier food choices
Questo accade perch il farmaco agisce finch presente nell'organismo, ma non modifica le abitudini alimentari e lo stile di vita